Differences in the management of hypertension, diabetes mellitus and dyslipidemia between obesity classes

• Published in: Journal of human hypertension 2016-01, Vol.30 (1), p.7-10
• Main Authors: Martínez-St John, D R J, Palazón-Bru, A, Gil-Guillén, V F, Sepehri, A, Navarro-Cremades, F, Orozco-Beltrán, D, Carratalá-Munuera, C, Cortés, E, Rizo-Baeza, M M
• Format: Article
• Language: English
• Subjects: 692/499; 692/700/139; 692/700/459/1748; Adult; Care and treatment; Cross-Sectional Studies; Diabetes Mellitus - epidemiology; Diabetes Mellitus - etiology; Diabetes Mellitus - therapy; Diabetes therapy; Disease Management; Dyslipidemias - epidemiology; Dyslipidemias - etiology; Dyslipidemias - therapy; Epidemiology; Female; Health Administration; Humans; Hypertension; Hypertension - epidemiology; Hypertension - etiology; Hypertension - therapy; Male; Medicine; Medicine & Public Health; Middle Aged; Obesity; Obesity - classification; Obesity - complications; Obesity - epidemiology; original-article; Practice Patterns, Physicians' - statistics & numerical data; Public Health
• ISSN: 0950-9240; 1476-5527
• DOI: 10.1038/jhh.2015.29

We did not find any paper that assessed clinical inertia in obese patients. Therefore, no paper has compared the clinical inertia rates between morbidly and nonmorbidly obese patients. A cross-sectional observational study was carried out. We analysed 8687 obese patients ⩾40 years of age who attended their health-care center for a checkup as part of a preventive program. The outcome was morbid obesity. Secondary variables were as follows: failure in the management of high blood pressure (HBP), high blood cholesterol (HBC) and high fasting blood glucose (HFBG); gender; personal history of hypertension, dyslipidemia, diabetes, smoking and cardiovascular disease; and age (years). We analysed the association between failures and morbid obesity by calculating the adjusted odds ratio (OR). Of 8687 obese patients, 421 had morbid obesity (4.8%, 95% confidence interval (CI): 4.4–5.3%). The prevalence rates for failures were as follows: HBP, 34.7%; HBC, 35.2%; and HFBG, 12.4%. Associated factors with morbid obesity related with failures were as follows: failure in the management of HBP (OR=1.42, 95% CI: 1.15–1.74, P =0.001); failure in the management of HBC (OR=0.73, 95% CI: 0.58–0.91, P =0.004); and failure in the management of HFBG (OR=2.24, 95% CI: 1.66–3.03, P